Literature DB >> 31720934

Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.

Rodney E Wegner1, Stephen Abel2, Dulabh Monga3, Moses Raj3, Gene Finley3, Stanislav Nosik4, James McCormick4, Alexander V Kirichenko2.   

Abstract

BACKGROUND: Adjuvant radiation is generally not recommended for colon cancer but may be considered in certain clinical scenarios [advanced local disease (pT4) and/or positive margins]. Guidelines in this area are lacking; thus we analyzed the National Cancer Database (NCDB) for patterns of care in this regard and any predictors for outcome.
METHODS: We queried the NCDB from 2004 to 2016 for patients with resected adenocarcinoma of the colon having pT4 and/or had positive margins on final pathology and who received adjuvant multiagent chemotherapy. Multivariable logistic regression was used to identify predictors of adjuvant radiation. A propensity score was used to perform matched Kaplan-Meier analysis. Propensity-adjusted Cox regression was used to identify predictors of overall survival.
RESULTS: We identified 23,325 patients meeting criteria, of whom 1711 (7%) received adjuvant radiation. Median follow-up was 36 months. The majority of patients were pT4 alone (65%). Predictors of adjuvant radiation were lower comorbidity score, younger age, more remote year of treatment, and both pT4 and positive margins. Kaplan-Meier analysis revealed improved overall survival (OS) in patients with both pT4 and positive margins treated with radiation (median OS: 66 versus 47 months, p = 0.02). Receipt of adjuvant radiation was associated with improved OS [hazard ratio (HR): 0.86 (0.80-0.93) p = 0.0002] on Cox regression analysis. Increased age, higher comorbidity score, lower income, government insurance, and combined pT4/positive margins were indicative of worse survival.
CONCLUSIONS: Expectedly, adjuvant radiation use was relatively low but was associated with improved OS in patients with both pT4 and positive margins.

Entities:  

Year:  2019        PMID: 31720934     DOI: 10.1245/s10434-019-08042-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study.

Authors:  Yaobin Lin; Shan Liu; Liang Hong; Lingdong Shao; Junxin Wu
Journal:  Radiat Oncol       Date:  2022-05-13       Impact factor: 4.309

2.  Prognostic analysis and beneficiary identification of adjuvant external beam radiotherapy for stage pT4b sigmoid colon cancer.

Authors:  Yaobin Lin; Lei Wang; Lingdong Shao; Xueqing Zhang; Huaqin Lin; Youjia Wang; Junxin Wu
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

3.  Female Colon Cancer Metastasis Pattern and Prognosis: A SEER-Based Study.

Authors:  Yurong Liu; Rongbin Kang; Huida Zheng; Pengcheng Wang; Weixin Jiang; Bin Xiong; Jintao Chen; Jianhua Xu
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

4.  Nonadherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky.

Authors:  Zeta Chow; Tong Gan; Quan Chen; Bin Huang; Nancy Schoenberg; Mark Dignan; B Mark Evers; Avinash S Bhakta
Journal:  J Am Coll Surg       Date:  2020-02-13       Impact factor: 6.532

5.  Serum zinc level and tissue ZIP4 expression are related to the prognosis of patients with stages I-III colon cancer.

Authors:  Xin Wu; Han Wu; Liyang Liu; Guanghui Qiang; Jianwei Zhu
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.